Welcome to MutualFunds.com. Please help us personalize your experience.
Your personalized experience is almost ready.
Check your email and confirm your subscription to complete your personalized experience.
Thank you for your submission, we hope you enjoy your experience
So far in 2015, the fund is up about 11%, which is in-line with the iShares NASDAQ Biotechnology Index (IBB) and well above the S&P 500 index, which is up about 3%.
Nearly 30% of the fund’s portfolio is comprised of its top 5 holdings.
|Symbol||Stock||Portfolio Weight||YTD Performance|
Subscribe to receive FREE updates, insigns, and more, straight to your inbox